ArticleBone marrow transplantation2025

Timing of achieving MRD negativity for B-ALL patients with IKZF1 alterations in CR1 may dictate transplant decision: Autologous versus Allogeneic HSCT.

Jiali Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.